Cargando…
Identification of Novel Small-Molecule Kinase Modulators for the Treatment of Neuroblastoma
Neuroblastoma represents 8–10% of all childhood cancer cases and is responsible for 15% of all cancer-related deaths in infants. Even though patients with low- and intermediate-risk disease have a good prognosis, the 5-year survival rate of the vast majority of patients with high-risk neuroblastoma...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359976/ https://www.ncbi.nlm.nih.gov/pubmed/32700077 http://dx.doi.org/10.1007/s40487-020-00113-5 |